SE447113B - INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN - Google Patents
INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANINInfo
- Publication number
- SE447113B SE447113B SE8304549A SE8304549A SE447113B SE 447113 B SE447113 B SE 447113B SE 8304549 A SE8304549 A SE 8304549A SE 8304549 A SE8304549 A SE 8304549A SE 447113 B SE447113 B SE 447113B
- Authority
- SE
- Sweden
- Prior art keywords
- mixture
- hydroxyethoximethyl
- give
- acid
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Description
447 115 2 Enligt patentansökan 7709606-3 har man funnit att vissa 9-(2- -hydroxietoximetyl)derivat av puriner kan framställas via en ny och fördelaktig syntesväg. Den nämnda patentansökan 7709606-3 avser så- lunda ett förfarande för framställning av föreningar med formeln (I) (15 CH2.0.CH2.Ch2.0H vari R betecknar amino eller hydroxi; varvid en förening med formeln (II) 2 CHZOCHZCHZ-O-C-X 2-CXl och X1 och X2 är lika eller II O olika och vardera betecknar en lägre alkylgrupp, och R2 betecknar väte eller -Cxl under förutsättning att R2 betecknar väte då Rl be- H O tecknar hydroxi, hydrolyseras i närvaro av en bas. Alkylgruppen har företrädesvis l-4 kolatomer och helst är X1 och X identiska och betecknar var och en en metylgrupp. According to patent application 7709606-3, it has been found that certain 9- (2-hydroxyethoxymethyl) derivatives of purines can be prepared via a new and advantageous synthetic route. The said patent application 7709606-3 thus relates to a process for the preparation of compounds of formula (I) (CH2.0.CH2.Ch2.0H wherein R represents amino or hydroxy; wherein a compound of formula (II) 2 CHZOCHZCHZ- OCX 2 -CX1 and X1 and X2 are the same or II 0 different and each represents a lower alkyl group, and R2 represents hydrogen or -Cx1 provided that R2 represents hydrogen when R1 represents hydroxy, hydrolyzed in the presence of a base. preferably has 1-4 carbon atoms and most preferably X 1 and X are identical and each represents a methyl group.
Mellanprodukterna med formeln (II) är nya och föreliggande upp- finning åstadkommer, såsom mellanprodukter, föreningar med formeln (II) enligt ovan. Dessa föreningar kan framställas genom att man vari Rl betecknar hydroxi eller -NR bringar guanin eller 2-aminoadenin, vari 2- och 9-, respektive 2-, 6- och 9-ställningarna är acylerade, att reagera med en diester av 2~oxa-1,4-butandiol i närvaro av en katalytisk mängd av en stark syra, såsom svavelsyra, sulfonsyror såsom p-toluensulfonsyra, metan- sulfonsyra eller trifluormetansulfonsyra, sulfamsyra, bis-(p-nitro- fenyl)fosfat eller polyfosforsyra. s 447 115 Den acylerade purinen kan i sin tur framställas genom att man bringar att reagera motsvarande purin med en syraanhydrid, såsom ättiksyraanhydrid, eller annat acylerande medel, t ex syrahalogenid.The intermediates of formula (II) are novel and the present invention provides, as intermediates, compounds of formula (II) as above. These compounds can be prepared by reacting with guanine or 2-aminoadenine in which R1 represents hydroxy or -NR, wherein the 2- and 9-, respectively 2-, 6- and 9-positions are acylated, to react with a diester of 2-oxa -1,4-butanediol in the presence of a catalytic amount of a strong acid such as sulfuric acid, sulfonic acids such as p-toluenesulfonic acid, methanesulfonic acid or trifluoromethanesulfonic acid, sulfamic acid, bis- (p-nitrophenyl) phosphate or polyphosphoric acid. The acylated purine can in turn be prepared by reacting the corresponding purine with an acid anhydride, such as acetic anhydride, or other acylating agent, for example acid halide.
För framställning av diestern av 2-oxa-1,4-butandiol, bringas dioxolan att reagera med en syraanhydrid i närvaro av en katalytisk mängd av en stark syra, t ex en av dem som uppräknats ovan.To prepare the diester of 2-oxa-1,4-butanediol, dioxolane is reacted with an acid anhydride in the presence of a catalytic amount of a strong acid, for example one of those listed above.
Uppfinningen, vars kännetecken framgår av de efterföljan- de patentkraven, kommer nu att åskådliggöras med hänvisning till följande exempel, som belyser framställning av mellan- produkterna enligt uppfinningen och deras användning för fram- ställning av föreningar med formeln (I).The invention, the characteristics of which appear from the appended claims, will now be illustrated with reference to the following examples, which illustrate the preparation of the intermediates according to the invention and their use for the preparation of compounds of formula (I).
EXEMPEL l 9-(2-hydroxigtoximetyl)guanin En blandning av ättiksyraanhydrid (102 g), ättiksyra (15 g) och p-toluensulfonsyra (5,0 g), som kylts till l0°C försattes med dioxolan (70 g) under omröring och kylning i sådan utsträckning att temperaturen i reaktionskärlet aldrig översteg 40°C. Blandningen kyldes sedan till rumstemperatur och toluen (300 ml) och diacetyl- guäflin (50 g) tillsattes. Reaktionsblandningen uppvärmdes sedan till återloppskokning under omröring i 16 h. Den kyldes sedan till rumstemperatur, kloroform (50 ml) tillsattes och den fasta produkten avlägsnades genom filtrering. Filterkakan tvättades omsorgsfullt med kloroform och torkades för att ge 2-acetamido-9- *(2'äCetOXiet0Ximetyl)-hypoxantin. Den torkade filterkakan sattes till 40 % vattenhaltig metylamin (350 ml), och blandningen uppvärmdes till âterflödeskokning under omröring i 40 min, kyl- des och filtrerades. Filtratet indunstades under förminskat tryck till en uppslamning. Ubpslamningen kyldes och filtrerades, och filterkakan tvättades med etanol och torkades, varvid man erhöll 9-(2-hydroxietoximetyl)guanin (27 g, mer än 90 %-ig renhet) smp 255-257°C, utbyte = 56 %.EXAMPLE 1 9- (2-Hydroxyethoxymethyl) guanine A mixture of acetic anhydride (102 g), acetic acid (15 g) and p-toluenesulfonic acid (5.0 g), cooled to 10 ° C, was added with dioxolane (70 g) with stirring. and cooling to such an extent that the temperature in the reaction vessel never exceeded 40 ° C. The mixture was then cooled to room temperature and toluene (300 ml) and diacetylguane (50 g) were added. The reaction mixture was then heated to reflux with stirring for 16 hours. It was then cooled to room temperature, chloroform (50 ml) was added and the solid product was removed by filtration. The filter cake was washed thoroughly with chloroform and dried to give 2-acetamido-9- * (2'-CetOXietloxymethyl) -hypoxanthine. The dried filter cake was added to 40% aqueous methylamine (350 ml), and the mixture was heated to reflux with stirring for 40 minutes, cooled and filtered. The filtrate was evaporated under reduced pressure to a slurry. The slurry was cooled and filtered, and the filter cake was washed with ethanol and dried to give 9- (2-hydroxyethoxymethyl) guanine (27 g, greater than 90% purity) mp 255-257 ° C, yield = 56%.
EXEMEL 2 2: lZztrëzeëisteëiiflstzllssëaia En blandning av diacetylguanin (50 g), 2-oxa-l,4-butandiol- diacetat (59,8 g), och p-toluensulfonsyra (1,2 g) i toluen (350 ml) uppvärmdes under omröring till âterloppskokning i 16 h. Bland- ningen kyldes till rumstemperatur, filtrerades och filterkakan tvättades omsorgsfullt med toluen för att ge 2-acetamido-9~(2-acet_ oxletoximetyl)-hypoxantin. Filterkakan torkades och till- 447g11s 4 sattes till 40 % vattenhaltig metylamin (350 ml). Blandningen upp- värmdes under återloppskokning och omröring i 40min, kyldes till rumstemperatur och filtrerades. Filtratet indunstades under för- minskat tryck, varvid man erhöll en tjock uppslamning. Etanol (200 ml) tillsattes till uppslamningen, som sedan kyldes, filtre- rades, tvättades med etnaol och torkades, varvid man erhöll 9-(2-hydroxietoximetyl)guanin (36 g, mer än 90 %-ig renhet), utbyte = 75 %.EXAMPLE 2 2: Streets A mixture of diacetylguanine (50 g), 2-oxa-1,4-butanediol diacetate (59.8 g), and p-toluenesulfonic acid (1.2 g) in toluene (350 ml) was heated under stirring to reflux for 16 hours. The mixture was cooled to room temperature, filtered and the filter cake was washed thoroughly with toluene to give 2-acetamido-9 - (2-acetoxytoxymethyl) -hypoxanthine. The filter cake was dried and 447 g / l 4 was added to 40% aqueous methylamine (350 ml). The mixture was heated under reflux and stirring for 40 minutes, cooled to room temperature and filtered. The filtrate was evaporated under reduced pressure to give a thick slurry. Ethanol (200 ml) was added to the slurry, which was then cooled, filtered, washed with ethanol and dried to give 9- (2-hydroxyethoxymethyl) guanine (36 g, more than 90% purity), yield = 75 %.
EXEMEL 3 2:acetamido-9-(2-acetyloxietoximetyl)hypoxantin En blandning av diacetylguanin (1,0 g) 2-oxa-l,4-butandio1- diacetat (0,82 g) och p-toluensulfonsyra (23 mg) i mineralolja (4 g) uppvärmdes vid 1l5°C under omröring vid reducerat tryck över natten. Mineraloljan avdekanterades. Återstoden triturera- des med kloroform och extraherades med kokande metanol. Metanol- extraktet koncentrerades till 50 ml, kyldes och filtrerades.EXAMPLE 3 2: Acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine A mixture of diacetylguanine (1.0 g) 2-oxa-1,4-butanediol-diacetate (0.82 g) and p-toluenesulfonic acid (23 mg) in mineral oil (4 g) was heated at 115 ° C with stirring under reduced pressure overnight. The mineral oil was decanted. The residue was triturated with chloroform and extracted with boiling methanol. The methanol extract was concentrated to 50 ml, cooled and filtered.
Filtratet indunstades till torrhet, varvid man erhöll en fast återstod (0,43 g). Den fasta återstoden renades med kolonnkroma- tografi (silikagel, 10 g, i kloroform, eluerad med 1:1 kloro- form:aceton), varefter följde omkristallisation ur etanol varvid man erhöll 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin (o,14 g), smp 2o2,s-2o4,5°c.The filtrate was evaporated to dryness to give a solid residue (0.43 g). The solid residue was purified by column chromatography (silica gel, 10 g, in chloroform, eluting with 1: 1 chloroform: acetone), followed by recrystallization from ethanol to give 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine ( o, 14 g), mp 2o2, s-2o4,5 ° c.
EXEMPEL 4 2:amino-9-(2-hydrogietoximetyl)adenin (a) 2-formamidoadenin (89,0 g) placerades i en 5 liters flaska utrustad med luftomrörare och återloppskylare (CaCl2- -torkrör), till vilket man satte ättiksyraanhydrid (4 liter).EXAMPLE 4 2: Amino-9- (2-hydrogietoxymethyl) adenine (a) 2-formamidoadenine (89.0 g) was placed in a 5 liter flask equipped with an air stirrer and reflux condenser (CaCl 2 - drying tube), to which was added acetic anhydride ( 4 liters).
Blandningen fick återloppskoka i 60 h. Vid slutet av denna tids- period avlägsnades anhydridöverskottet genom destillation vid atmosfärstryck tills ungefär 3,5 liter destillat erhållits.The mixture was refluxed for 60 hours. At the end of this time, the excess anhydride was removed by distillation at atmospheric pressure until about 3.5 liters of distillate were obtained.
Destillationen fortsattes under förminskat tryck för avlägsnan- de av större delen av kvarvarande anhydrid. En mörkbrun återstod i reaktionskärlet blev en viskös gummiartad massa vid kylning till rumstemperatur och denna massa upplöstes sedan i diklormetan, filtrerades för avlägsnande av suspenderat fast material, och lösningsmedlet avlägsnades i vakuum, varvid man erhöll 211,0 g (* 100 %) 2,6-bis-(diacetylamino)-9-acetylpurin. Det analyserade utbyte var 96,7 % baserat på NMR och resten av materialet ut- gjordes av ättiksyraanhydrid. 5 447 113 (b) Penta-acetylpurin (174 g) förenades med 1,4-diacetoxi- -2-oxabutan (l26,8 g) i en flaska, som var utrustad med luft- omröring och torkrör. Blandningen placerades sedan i ett olje- bad vid l30°C ochcxmürdes under några få minuter för homogenisering av satsen. Syrakatalysatorn, paratoluensulfonsyran (2,74 g), tillsattes sedan i en portion och uppvärmningen fortsattes i vakuum under 4 h, under vilken tidsperiod en nästan kvantitativ omvandling till produkter observerades. Reaktionsblandningen kyl- des sedan till rumstemperatur ochden lagrades i torr kvävgas. (c) Fusionsprodukten (208,5 g) löstes i etanol (5 ml/g) vid rumstemperatur och överfördes tillen fuska, som var utrustad med dropptratt, luftomröring och termometer. n-butylamin (l40,4 g) tillsattes sedan droppvis under en period på 2 h och den exoterma reaktionen nxfleflfibsneíhjälp av ettvattenbad. Den högsta tempera- tur, som reaktionsblandningen fick anta var endast 30°C. Produkten började skiljas från reaktionsblandningen under additionsförlop- pet. Efter fullbordad tillsatsomrördes blandningen vid rums- temperatur i 3 h varefter den placerades i kallt rum över natten.Distillation was continued under reduced pressure to remove most of the remaining anhydride. A dark brown residue in the reaction vessel became a viscous gummy mass on cooling to room temperature and this mass was then dissolved in dichloromethane, filtered to remove suspended solids, and the solvent removed in vacuo to give 211.0 g (* 100%) 2. 6-bis- (diacetylamino) -9-acetylpurine. The analyzed yield was 96.7% based on NMR and the rest of the material was acetic anhydride. 5,447,113 (b) Pentaacetylpurine (174 g) was combined with 1,4-diacetoxy-2-oxabutane (26.8 g) in a flask equipped with air agitator and drying tube. The mixture was then placed in an oil bath at 130 ° C and stirred for a few minutes to homogenize the batch. The acid catalyst, the paratoluenesulfonic acid (2.74 g), was then added in one portion and heating was continued in vacuo for 4 hours, during which time an almost quantitative conversion to products was observed. The reaction mixture was then cooled to room temperature and stored in dry nitrogen. (c) The fusion product (208.5 g) was dissolved in ethanol (5 ml / g) at room temperature and transferred to a cheat equipped with a dropping funnel, air stirrer and thermometer. n-Butylamine (140.4 g) was then added dropwise over a period of 2 hours and the exothermic reaction nx fl e flfi bsneí help of a water bath. The highest temperature that the reaction mixture was allowed to assume was only 30 ° C. The product began to separate from the reaction mixture during the addition process. After completion of the addition, the mixture was stirred at room temperature for 3 hours, after which it was placed in a cold room overnight.
Produkten avlägsnades genom filtrering, varvid man erhöll en pasta- liknande massa, som uppslammades med aceton 1 x 500 ml) och om- filtrerades. Denna massa torkades i vakuum vid 65°C i 3 h och sedan vid rumstemperatur över natten, varvid man erhöll l54,2 g (9l,7 %) av en ljusbrun hård susbstans. Produkten renades genom att man löste den i het dimetylformamid (lO ml/g) vid 100-llO°C för bild- ning av en opakbrun lösning. Efter kylning över natten vid 5°C avlägsnades produkten genom filtrering, tvättades med aceton (l x 250 ml) och lufttorkades, varvid man erhöll 121,7 g (78,8 %) 2,6-diacetamido-9-(2-acetoxietoximetyl)purin. (d) 2,6-diacetamido-9-(2-acetoxietoximetyl)purin (121,7 g) tillsattes till en omrörd lösning av vattenhaltig metylamin (608,5 ml av 40 % lösning) under en 5 min period. Tillsatsen åtföljdes av en svagt exotermisk reaktion, som höjde blandningens temperaturtill35¶3od~allt fast material upplöstes på några få minuter. Efter omröring i 2 l/2 h visade tunnskiktskromatografi av blandningen att reaktionen var fullbordad. Blandningen koncen- trerades sedan i vakuum på vattenbad vid 45-5000, varvid man er- höll tjock massa av bruna kristaller. Denna massa uppslammades sedan med aceton (545 ml, 7 ml/g) i l5 min för avlägsnande av 447 113 6 N-metylacetamid och vakuumfiltrerades. Kakan sköljdes me (1 x 200 ml) och lufttorkades, varvid man erhöll 74,7 g oren, hydratiserad 2-amino-9-(2-hydroxietoximetyl)adenin ljusbruna kristaller. Dessa torkades i vakuum vid 80°C i varvid man erhöll 69,3 g (89,0 %) torr produkt.The product was removed by filtration to give a paste-like mass which was slurried with acetone (1 x 500 ml) and re-filtered. This mass was dried in vacuo at 65 ° C for 3 hours and then at room temperature overnight to give 155.2 g (91, 7%) of a light brown hard substance. The product was purified by dissolving it in hot dimethylformamide (10 ml / g) at 100-110 ° C to give an opaque brown solution. After cooling overnight at 5 ° C, the product was removed by filtration, washed with acetone (1 x 250 ml) and air dried to give 121.7 g (78.8%) of 2,6-diacetamido-9- (2-acetoxyethoxymethyl). purin. (d) 2,6-Diacetamido-9- (2-acetoxyethoxymethyl) purine (121.7 g) was added to a stirred solution of aqueous methylamine (608.5 ml of 40% solution) over a 5 minute period. The addition was accompanied by a slight exothermic reaction which raised the temperature of the mixture to 35 ° C and all solids dissolved in a few minutes. After stirring for 2 l / 2 h, thin layer chromatography of the mixture showed that the reaction was complete. The mixture was then concentrated in vacuo on a water bath at 45-5000 to give a thick mass of brown crystals. This mass was then slurried with acetone (545 ml, 7 ml / g) for 15 minutes to remove 447,113 N-methylacetamide and vacuum filtered. The cake was rinsed with (1 x 200 ml) and air dried to give 74.7 g of crude, hydrated 2-amino-9- (2-hydroxyethoxymethyl) adenine light brown crystals. These were dried in vacuo at 80 ° C to give 69.3 g (89.0%) of dry product.
EXEMPEL 5 6,19 g 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin suspen- derades i 40 ml natriumhydroxid och uppvärmdes under återflöde i 1 h. Blandningen kyldes, neutraliserades med 6N klorvätesyra och produkten filtreraåes av-Fastämnet tvättades med 10 ml isvatten och med 15 ml aceton och torkades över natten under vakuum. 4,13 g (9l,8%) 9-(2-hydroxietoxïmetyl)guanin erhölls, smältpunkt 255-257°c; EXEMPEL 6 6,19 g 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin upp- slammades i en lösning av 3,24 g natriummetylat i 40 ml metanol.EXAMPLE 5 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine was suspended in 40 ml of sodium hydroxide and heated under reflux for 1 hour. The mixture was cooled, neutralized with 6N hydrochloric acid and the product was filtered off. The solid was washed with 10 ml. ice water and with 15 ml of acetone and dried overnight under vacuum. 4.13 g (91, 8%) of 9- (2-hydroxyethoxymethyl) guanine were obtained, m.p. 255-257 ° C; EXAMPLE 6 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine were slurried in a solution of 3.24 g of sodium methylate in 40 ml of methanol.
Bladningen uppvärmdes under återflöde i 1 h och fick svalna. 3,96 g isättika tillsattes och blandningen hälldes i 40 ml vatten.The mixture was heated under reflux for 1 hour and allowed to cool. 3.96 g of glacial acetic acid were added and the mixture was poured into 40 ml of water.
Efter kylning, OOC, filtrerades den resulterande fällningen, tvät- tades med 15 ml kallt vatten och med 15 ml aceton och torkades under vakuum, vilket gav 4,03 g (89,6%) 9-(2-hydroxietoximetyl)- guanin, smältpunkt 255-25700.After cooling, 0 ° C, the resulting precipitate was filtered, washed with 15 ml of cold water and with 15 ml of acetone and dried under vacuum to give 4.03 g (89.6%) of 9- (2-hydroxyethoxymethyl) guanine. melting point 255-25700.
EXEMPEL 7 6,19 g 2-acetamido~9-(2-acetyloxietoximetyl)hypoxantin sattes till en lösning av 3,96 g kaliumhydroxid i 40 ml etanol och upp- värmdes under återflöde i l h. Blandningen fick svalna och 3,96 g isättika tillsattes. Bladningen hälldes i 40 ml vatten och 50 ml vatten tillsattes. pH-värdet justerades till 7,0 med vattenhaltig natriumhydroxid och blandningen kyldes med isvatten och filtrera- des. Fastämnet tvättades med 20 ml kallt vatten och med 20 ml aceton och torkades under vakuum för att ge 4,0 g (88,9%) 9-(2-hydroxietoximetyl)guanin, smältpunkt 255-257°C.EXAMPLE 7 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine was added to a solution of 3.96 g of potassium hydroxide in 40 ml of ethanol and heated under reflux for 1 hour. The mixture was allowed to cool and 3.96 g of glacial acetic acid was added. The mixture was poured into 40 ml of water and 50 ml of water was added. The pH was adjusted to 7.0 with aqueous sodium hydroxide and the mixture was cooled with ice water and filtered. The solid was washed with 20 ml of cold water and with 20 ml of acetone and dried under vacuum to give 4.0 g (88.9%) of 9- (2-hydroxyethoxymethyl) guanine, m.p. 255-257 ° C.
EXEMPEL 8» 6,19 g 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin upp- slammades med 5 mg trietylamin och 40 ml vatten och blandningen uppvärmdes under återflöde i 2 h. Blandningen fick svalna till OOC och filtrerades. Fastämnet tvättades med 15 ml vatten och med 15 ml aceton och torkades under vakuum, vilket gav 4,34 g (96%) 9-(2-hydroxietoximetyl)guanin, smältpunkt 255-257°C.EXAMPLE 8 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine were slurried with 5 mg of triethylamine and 40 ml of water and the mixture was heated under reflux for 2 hours. The mixture was allowed to cool to 0 ° C and filtered. The solid was washed with 15 ml of water and with 15 ml of acetone and dried under vacuum to give 4.34 g (96%) of 9- (2-hydroxyethoxymethyl) guanine, m.p. 255-257 ° C.
Claims (2)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71810576A | 1976-08-27 | 1976-08-27 | |
US05/773,135 US4146715A (en) | 1975-08-27 | 1977-02-28 | 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8304549L SE8304549L (en) | 1983-08-23 |
SE8304549D0 SE8304549D0 (en) | 1983-08-23 |
SE447113B true SE447113B (en) | 1986-10-27 |
Family
ID=27109837
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7709606A SE432764B (en) | 1976-08-27 | 1977-08-26 | PROCEDURE FOR PREPARING 2-AMINO-9- (2-HYDROXYETOXIMETHYL) ADENIN AND 9- (2-HYDROXYTOXYMETHYL) GUANINE |
SE8304549A SE447113B (en) | 1976-08-27 | 1983-08-23 | INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7709606A SE432764B (en) | 1976-08-27 | 1977-08-26 | PROCEDURE FOR PREPARING 2-AMINO-9- (2-HYDROXYETOXIMETHYL) ADENIN AND 9- (2-HYDROXYTOXYMETHYL) GUANINE |
Country Status (12)
Country | Link |
---|---|
AT (1) | AT357566B (en) |
CA (2) | CA1096863A (en) |
CH (1) | CH634843A5 (en) |
CS (1) | CS196384B2 (en) |
DD (1) | DD131856A6 (en) |
DK (1) | DK147857C (en) |
FI (1) | FI64160C (en) |
GB (1) | GB1567671A (en) |
NL (1) | NL7709458A (en) |
NO (2) | NO147186C (en) |
SE (2) | SE432764B (en) |
YU (1) | YU41079B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880820A (en) * | 1983-06-24 | 1989-11-14 | Merck & Co., Inc. | Guanine derivatives |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
US4918219A (en) * | 1983-10-31 | 1990-04-17 | Warner-Lambert Company | Glycerine derivatives |
YU45690B (en) * | 1984-12-22 | 1992-07-20 | Krka Tovarna Zdraviln.Sol.O. | PROCEDURE FOR PREPARING 9- (2-HYDROXYETHOXYMETHYL) -GUANINE |
EP0564006A3 (en) * | 1987-05-04 | 1993-12-15 | Krka Tovarna Zdravil | Process for preparing purine derivatives and novel purine derivatives |
US5756737A (en) * | 1993-09-10 | 1998-05-26 | Recordati S.A. Chemical And Pharmaceutical Company | Process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine |
DE19536164A1 (en) * | 1995-09-28 | 1997-04-03 | Boehringer Ingelheim Kg | Improved Process for the Production of 9 - [(2-Hydroxyethoxy) methyl] guanine (Acyclovir) |
IT1276126B1 (en) * | 1995-11-14 | 1997-10-27 | Archimica Spa | PROCEDURE FOR THE PREPARATION OF 9 - ((2-HYDROXYETHOXY) METHYL) GUANINE |
WO1997024357A1 (en) * | 1995-12-28 | 1997-07-10 | Mallinckrodt Chemical, Inc. | Process for synthesis and purification of a compound useful in the preparation of acyclovir |
-
1977
- 1977-08-24 YU YU2022/77A patent/YU41079B/en unknown
- 1977-08-26 NL NL7709458A patent/NL7709458A/en active Search and Examination
- 1977-08-26 AT AT620177A patent/AT357566B/en not_active IP Right Cessation
- 1977-08-26 NO NO772959A patent/NO147186C/en unknown
- 1977-08-26 CH CH1046677A patent/CH634843A5/en not_active IP Right Cessation
- 1977-08-26 CS CS775615A patent/CS196384B2/en unknown
- 1977-08-26 FI FI772548A patent/FI64160C/en not_active IP Right Cessation
- 1977-08-26 DK DK380377A patent/DK147857C/en not_active IP Right Cessation
- 1977-08-26 GB GB35914/77A patent/GB1567671A/en not_active Expired
- 1977-08-26 CA CA285,592A patent/CA1096863A/en not_active Expired
- 1977-08-26 DD DD7700200760A patent/DD131856A6/en not_active IP Right Cessation
- 1977-08-26 SE SE7709606A patent/SE432764B/en not_active IP Right Cessation
-
1980
- 1980-06-20 CA CA354,538A patent/CA1096864A/en not_active Expired
-
1982
- 1982-07-20 NO NO822502A patent/NO150119C/en unknown
-
1983
- 1983-08-23 SE SE8304549A patent/SE447113B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB1567671A (en) | 1980-05-21 |
SE432764B (en) | 1984-04-16 |
YU41079B (en) | 1986-12-31 |
NO147186B (en) | 1982-11-08 |
DK380377A (en) | 1978-02-28 |
CS196384B2 (en) | 1980-03-31 |
NO150119C (en) | 1984-08-22 |
ATA620177A (en) | 1979-12-15 |
NO772959L (en) | 1978-02-28 |
DD131856A6 (en) | 1978-07-26 |
YU202277A (en) | 1983-02-28 |
DK147857B (en) | 1984-12-24 |
CH634843A5 (en) | 1983-02-28 |
NO822502L (en) | 1978-02-28 |
CA1096863A (en) | 1981-03-03 |
FI772548A (en) | 1978-02-28 |
NL7709458A (en) | 1978-03-01 |
NO150119B (en) | 1984-05-14 |
SE8304549L (en) | 1983-08-23 |
SE7709606L (en) | 1978-02-28 |
NO147186C (en) | 1983-02-16 |
SE8304549D0 (en) | 1983-08-23 |
CA1096864A (en) | 1981-03-03 |
FI64160B (en) | 1983-06-30 |
FI64160C (en) | 1983-10-10 |
AT357566B (en) | 1980-07-25 |
DK147857C (en) | 1985-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Speer et al. | Some alkyl homologs of theophylline | |
SE447113B (en) | INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN | |
KR100218610B1 (en) | Preparation of n-9 substituted guanine compounds | |
Yamazaki et al. | Synthesis of inosine, 2-alkylinosine, and xanthosine from 5-amino-1-. beta.-D-ribofuranosyl-4-imidazolecarboxamide | |
CA1187874A (en) | Preparation of 1-substituted-2-amino-benzimidazoles | |
US3872082A (en) | Substituted purineribofuranoside-3,5-cyclophosphate compounds and process for their preparation | |
JPH0714937B2 (en) | Glyoxal-N2-guanine adduct and process for producing the same | |
Tronchet et al. | Chemistry and pharmacology of apoise. 7. Susceptibility of some branched-chain sugar nucleosides to enzymic deamination | |
US3029239A (en) | Basic substituted 1-and 7-alkylxanthines or salts thereof | |
Zecchini et al. | A new route to N2‐and N3‐substituted‐2, 3‐diaminopyridines. Synthesis of 1‐and 3‐alkoxycarbonyl‐v‐triazolo [4, 5‐b] pyridines | |
Joshi et al. | Benzoquinone derivatives. Part I. Reactions of primary aliphatic amines with embelin (2, 5-dihydroxy-3-undecyl-1, 4-benzoquinone) and di-o-methylembelin | |
CA1285936C (en) | 3-acylamino-3-deoxyallose derivatives | |
JPS633875B2 (en) | ||
CA1296001C (en) | 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them | |
JPS5859959A (en) | Aminosulfonic acid, its preparation and catalyst | |
Kokel | The reaction of N, N‐dimethyldichloromethyleniminium chloride (phosgeniminium chloride) with 6‐N‐arylaminouracils. A new and convenient “one pot” synthesis of l, 3‐dimethyl‐5‐dimethylaminopyrimido [4, 5‐b] quinoline‐(1H, 3H)‐2, 4‐diones, 1, 3‐dimethyl‐5‐chloropyrimido [4, 5‐b] quinoline‐(1H, 3H)‐2, 4‐diones and 3‐methyl‐10‐alkyl‐5‐chloropyrimido [4, 5‐b] quinoline‐(3H, 10H)‐2, 4‐diones (3‐methyl‐10‐alkyl‐5‐chloro‐5‐deazaflavins) | |
SU932991A3 (en) | Process for producing purine derivatives | |
SE457260B (en) | INTERMEDIATE FOR THE PREPARATION OF 2-METHYL ERGOPEPTINES AND SETTLE TO MANUFACTURE THE INTERMEDIATE PRODUCT | |
US2784188A (en) | Synthesis of 4, 5-diamino-6-dimethylamino pyrimidine | |
US2557721A (en) | 9, 10-dihydropteridines and process of preparing same | |
CA1089854A (en) | Pyrazolo[1,5-a]pyrido[4,3-d]pyrimidin-9(4h)- one and derivatives thereof | |
Gueiffier et al. | Conversion of imidazo [1, 2-a] pyridines into pyrido [1, 2-e] purines | |
PL108512B1 (en) | Method of producing purine derivatives | |
US5338741A (en) | 1-hydroxyalkylxanthines and medicaments containing them | |
JPS5946511B2 (en) | 1-(N-hydroxyalkylcarbamoyl)-5-fluorouracils and their production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8304549-2 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8304549-2 Format of ref document f/p: F |